We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
-$339M
Cap. Flow
-$282M
Cap. Flow %
-18.81%
Top 10 Hldgs %
41.55%
Holding
80
New
12
Increased
20
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$51M
2
NTRA icon
Natera
NTRA
+$41.9M
3
BDX icon
Becton Dickinson
BDX
+$37.3M
4
CYTK icon
Cytokinetics
CYTK
+$37M
5
ABT icon
Abbott
ABT
+$35M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$158M
2
BMY icon
Bristol-Myers Squibb
BMY
+$85.6M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$49.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$47.9M
5
THC icon
Tenet Healthcare
THC
+$40.9M

Sector Composition

Rank Sector Weight
1 Healthcare 91.96%
2 Consumer Discretionary 1.59%
3 Financials 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
51
Neurocrine Biosciences
NBIX
$16.6B
$2.2M 0.15%
23,480
-342,257
-94% -$29M
CYPH
52
Cypherpunk Technologies Inc
CYPH
$73.3M
$1.87M 0.12%
106,669
– –
IMA
53
ImageneBio Inc
IMA
$64.6M
$1.75M 0.12%
23,968
– –
LKFT
54
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.47M 0.1%
+23,740
New +$1.45M
JAZZ icon
55
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.43M 0.1%
9,170
-339,910
-97% -$49.3M
GERN icon
56
Geron
GERN
$949M
$1.22M 0.08%
+900,000
New +$1M
PCRX icon
57
Pacira BioSciences
PCRX
$997M
$1.06M 0.07%
+13,930
New +$929K
PYXS icon
58
Pyxis Oncology
PYXS
$236M
$879K 0.06%
217,457
-27,381
-11% -$200K
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$830K 0.06%
+13,570
New +$705K
LGV.WS
60
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$179K 0.01%
427,178
– –
EQRXW
61
DELISTED
EQRx, Inc. Warrant
EQRXW
$81K 0.01%
99,998
– –
OHPAW
62
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$43K ﹤0.01%
137,305
– –
MSACW
63
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$35K ﹤0.01%
82,663
– –
EUCRW
64
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$15K ﹤0.01%
78,059
– –
AVTR icon
65
Avantor
AVTR
$9.19B
– –
-428,380
Closed -$18.1M
BBIO icon
66
CALL
BridgeBio Pharma
BBIO
$16.5B
– –
-10,000
Closed -$167K
HALO icon
67
Halozyme
HALO
$12.2B
– –
-104,482
Closed -$4.2M
INSP icon
68
Inspire Medical Systems
INSP
$1.74B
– –
-17,490
Closed -$4.02M
JNJ icon
69
Johnson & Johnson
JNJ
$625B
– –
-279,810
Closed -$47.9M
MDT icon
70
CALL
Medtronic
MDT
$112B
– –
-275,000
Closed -$28.4M
MDT icon
71
Medtronic
MDT
$112B
– –
-1,530,580
Closed -$158M
VCYT icon
72
Veracyte
VCYT
$3.8B
– –
-119,710
Closed -$4.93M
XLV icon
73
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
– –
-254,230
Closed -$35.8M
NVRO
74
DELISTED
NEVRO CORP.
NVRO
– –
-409,230
Closed -$33.2M
AXNX
75
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-58,920
Closed -$3.3M
1 2
3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2022 Portfolio in Review

As of Q1 2022, HealthCor Management held 80 positions worth $1.5B, down 18% from $1.84B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

HealthCor Management withdrew a net $282M in Q1 2022, closing 16 positions and reducing 21 holdings. Its most notable exit was Medtronic, an estimated $158M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, HealthCor Management opened a new position in Becton Dickinson worth $37.6M.

  • HealthCor Management's largest Q1 2022 buy was Becton Dickinson: 144,997 shares worth $37.6M.
  • HealthCor Management added most to BioMarin Pharmaceuticals in Q1 2022, an estimated $51M increase.
  • HealthCor Management's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $85.6M.
  • HealthCor Management fully exited Medtronic in Q1 2022, selling an estimated $158M.
  • HealthCor Management's ten largest holdings make up 42% of its $1.5B portfolio in Q1 2022.
  • HealthCor Management opened 12 new positions and closed 16 in Q1 2022.
  • HealthCor Management's portfolio value fell 18% quarter-over-quarter to $1.5B.

Based on HealthCor Management's 13F filing for Q1 2022, filed 16 May 2022.